More articles about: Mental Health

Jenkins Foundation makes $3 million gift to the Kenneth and Frances Eisenberg and Family Depression Center to sustain outreach and community education programs.

Like many other mental health conditions, bipolar disorder is still quite stigmatized in our society. Stigma can play a significant role in how people living with bipolar disorder receive treatment and care, their education and careers, and many other aspects of daily life. For this episode, we’ll be tackling topics like medications, relationships, the workplace, and supporting a loved one. We’ll be hearing from Dr. Sagar Parikh, a psychiatrist in the Michigan Medicine Bipolar Disorder Clinic and professor of psychiatry and of health policy and management in the School of Public Health at UofM, and Michelle Yang, writer, activist, marketing project manager, and research participant with the Heinz C. Prechter Bipolar Research Program.

Research into conditions like bipolar disorder cannot happen without the participation of hundreds of people who sign up for research studies and programs like the Heinz C. Prechter Bipolar Research Program. In this episode, we’ll unpack wellness—how we define and measure it healthcare and research settings. We’re joined by Dr. Alexandra Vinson, assistant professor of Learning Health Sciences and co-lead of the Prechter Bipolar Disorder Learning Community. Stephanie Prechter, artist, philanthropist, a bipolar disorder research participant with lived experience and board member of the Prechter Program, and Dr. Sarah Sperry, director of the Emotion and Temporal Dynamics Lab and associate director of the Prechter Program.

Bipolar disorder is more than just mood swings. It’s a journey marked by intense highs of mania and debilitating lows of depression. But within this condition exist millions of people who live unique lives. Today, we're going to talk to three clinical and research experts from the Heinz C. Prechter Bipolar Research Program at Michigan Medicine to learn more about the science of bipolar disorder—diagnostics, genetics, and decision-making. We'll be hearing from Dr. Melvin McInnis, director of the Prechter Program, Dr. Paul Jenkins, associate professor of pharmacology and associate director of the Prechter Program, and Dr. Chandra Sripada, professor of psychiatry and philosophy.

In today's episode of The Fundamentals, we talk with Dr. John Ayanian, director of the U-M Institute for Healthcare Policy and Innovation. Dr. Ayanian's research explores underlying factors that contribute to persistent health disparities between minoritized groups and their white counterparts, as well as strategies for ending inequity in health care and improving overall health outcomes for everyone.

The Dr. Alvin B. and Aurelia E. Michaels Education Fund in Psychiatry brings leading mental health experts to U-M to share valuable insights with students, fellows, and faculty.

Concerns about telehealth’s potential to lead to more in-person care and higher costs are not panning out, which has implications for extending COVID-era flexibility.

Medical student Courtney Burns uses art to address secondary traumatic stress in anesthesiology, fostering emotional resilience and peer support in medicine.

Teams studying liver cancer, brain tumors, obesity medicine, CMV, sleep and memory, cancer immunotherapy aortic aneurysms and bipolar disorder are competing in STAT Madness

By studying veterans who went through suicide prevention appointments at VA hospitals and clinics, a study highlights key risk factors including access to firearms.

New safe gun storage laws for Michigan highlight the need for keeping firearms locked up and separate from ammunition to prevent injury and death including suicide.

People over 50 who work say having a job aids their mental and physical health, but disabilities, caregiving and other issues act as barriers to working for many, including those who aren’t working but aren’t yet retired.

Study suggests that the Adderall shortage did not cause many children to stop stimulant therapy altogether but may have led to them switching to alternative stimulants for ADHD.

Michigan Medicine mental health experts shares facts and information about addiction and treatment options available.

Hearing loss is one of the most common conditions of aging, affecting nearly two-thirds of older adults over the age of 70, but it’s not just a matter of diminished hearing. Hearing loss can contribute to poor psychosocial outcomes for patients including loneliness, depression, and social isolation. New research also shows that hearing loss is linked to a higher risk of cognitive decline and dementia. In fact, the 2024 Lancet Commission on Dementia Prevention, Intervention, and Care identified hearing loss as one of 14 modifiable risk factors for dementia. According to the commission, treating hearing loss could prevent up to 7% of dementia cases globally, making it one of the most impactful areas for potential prevention. This raises the question of whether use of hearing aids in people with hearing loss can reduce or mitigate this increased dementia risk. To help us understand these connections and the latest research in this area, we are joined today by Dr. Alison Huang, an epidemiologist and Senior Research Associate from the Johns Hopkins Cochlear Center for Hearing and Public Health. Her research studies the impact of sensory loss on cognitive and mental health in older adults. Dr. Huang was an author of the Aging and Cognitive Health Evaluation in Elders (ACHIEVE) study, a large, multicenter randomized controlled trial that tested whether treating hearing loss in older adults could help slow cognitive decline published in the Lancet. Alison Huang, PhD, MPH Link to article: Lin FR, Pike JR, Albert MS, Arnold M, Burgard S, Chisolm T, Couper D, Deal JA, Goman AM, Glynn NW, Gmelin T, Gravens-Mueller L, Hayden KM, Huang AR, Knopman D, Mitchell CM, Mosley T, Pankow JS, Reed NS, Sanchez V, Schrack JA, Windham BG, Coresh J; ACHIEVE Collaborative Research Group. Hearing intervention versus health education control to reduce cognitive decline in older adults with hearing loss in the USA (ACHIEVE): a multicentre, randomised controlled trial. Lancet. 2023 Sep 2;402(10404):786-797. doi: 10.1016/S0140-6736(23)01406-X. Epub 2023 Jul 18. PMID: 37478886; PMCID: PMC10529382.